CTX-M-93, a CTX-M variant lacking penicillin hydrolytic activity

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 1861-1866

  Djamdjian, Laura ^a   Naas, Thierry ^a   Tandé, Didier ^b   Cuzon, Gaelle ^a   Hanrotel Saliou, Catherine ^b   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 93; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; IMIPENEM; PENICILLIN G; PIPERACILLIN; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CATALYSIS; DRUG HYDROLYSIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SUBSTITUTION REACTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; ESCHERICHIA COLI; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PENICILLINS; PHYLOGENY; POLYMERASE CHAIN REACTION;

EID: 79955546687     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01656-10     Document Type: Article

References (37)

1. Ambler, R. P., et al. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-270.
2. Bae, I. K., et al. 2006. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. J. Antimicrob. Chemother. 58:315-319.
3. Bonnet, R., et al. 2001. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob. Agents Chemother. 45:2269-2275.
4. Bonnet, R., et al. 2003. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52:29-35.
5. Bös, F., and J. Pleiss. 2008. Conserved water molecules stabilize the Ω-loop in class A β-lactamase. Antimicrob. Agents Chemother. 52:1072-1079.
6. Bouallegue-Godet, O., et al. 2005. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43:1037-1044.
7. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
8. Carattoli, A., et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
9. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
10. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Coque, T. M., F. Baquero, and R. Canton. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 13(47):pii=19044. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044.
12. Cornish-Bowden, A. (ed.). 1995. Fundamentals of enzyme kinetics. Portland Press, Inc., Seattle, WA.
13. Delmas, J., F. Robin, F. Carvalho, C. Mongaret, and R. Bonnet. 2006. Prediction of the evolution of ceftazidime resistance in extended-spectrum β-lactamase CTX-M-9. Antimicrob. Agents Chemother. 50:731-738.
14. Delmas, J., et al. 2010. Structural insights into substrate recognition and product expulsion in CTX-M enzymes. J. Mol. Biol. 400:108-120.
15. Girlich, D., L. Poirel, A. Schlüter, and P. Nordmann. 2005. TLA-2, a novel Ambler class A expanded-spectrum beta-lactamase. Antimicrob. Agents Chemother. 49:4767-4770.
16. Hawkey, P. M., and A. M. Jones. 2009. The changing epidemiology of resistance. J. Antimicrob. Chemother. 6:i3-i10.
17. Ibuka, A., et al. 1999. Crystal structure of the E166A mutant of extended-spectrum β-lactamase Toho-1 at 1.8 Å resolution. J. Mol. Biol. 285:2079-2087.
18. Kieser, T. 1984. Factors affecting the isolation of cccDNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. (Pubitemid 14046088)
19. Lartigue, M. F., L. Poirel, and P. Nordmann. 2004. Diversity of genetic environment of blaCTX-M genes. FEMS Microbiol. Lett. 234:201-207.
20. Naas, T., D. Aubert, A. Ozcan, and P. Nordmann. 2007. Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii. Antimicrob. Agents Chemother. 51:1365-1372.
21. Naas, T., et al. 2006. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother. 58:178-182.
22. Naas, T., et al. 2008. Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene. Antimicrob. Agents Chemother. 52:1257-1263.
23. Naas, T., L. Poirel, and P. Nordmann. 2008. Minor extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl. 1):42-52.
24. Naas, T., C. Oxacelay, and P. Nordmann. 2007. Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob. Agents Chemother. 51:223-230.
25. Philippon, L. N., T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2188-2195.
26. Poirel, L., L. Brinas, A. Verlinde, L. Ide, and P. Nordmann. 2005. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3743-3748.
27. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.
28. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.
29. Poirel, L., et al. 2001. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:3355-3361.
30. Poirel, L., T. Naas, and P. Nordmann. 2008. Genetic support of extended-spectrum β-lactamases. Clin. Microbiol. Infect. 14:75-81.
31. Rossolini, G. M., M. M. D'Andrea, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl. 1):33-41.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Shimamura, T., et al. 2002. Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin. J. Biol. Chem. 277:46601-46608.
34. Stürenburg, E., A. Kühn, D. Mack, and R. Laufs. 2004. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J. Antimicrob. Chemother. 54:406-409.
35. Vakulenko, S., and D. Golemi. 2002. Mutant TEM β-lactamase producing resistance to ceftazidime, ampicillins, and β-lactamase inhibitors. Antimicrob. Agents Chemother. 46:646-653.
36. CTX-M-14 is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob. Agents Chemother. 53:5204-5212.
37. Wirth, T., et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151.